Listar por autor "Colombo, Nicoletta"
Mostrando ítems 1-9 de 9
-
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Han, Sileny; Oza, Amit; Colombo, Nicoletta; Raspagliesi, Francesco; Wenham, Robert M.; OAKNIN, ANA (Elsevier, 2023-11) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Wiley, 2021-10) -
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Poveda, Andres; Lheureux, S.; Cibula, David; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta; Lindemann, Kristina (Elsevier, 2022-03) -
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
DiSilvestro, Paul; Kim, Byoung-Gie; Oaknin Benzaquen, Ana Mazaltob; Scambia, Giovanni; Banerjee, Susana; Colombo, Nicoletta (American Society of Clinical Oncology, 2023-01-20) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (American Society of Clinical Oncology, 2020-10-20) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Oaknin Benzaquen, Ana Mazaltob; Lorusso, Domenica; Scambia, Giovanni; Colombo, Nicoletta (Elsevier, 2021-06) -
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
Colombo, Nicoletta; Van Gorp, Toon; Grisham, Rachel; Fleming, Gini; Matulonis, Ursula; OAKNIN, ANA (American Society of Clinical Oncology, 2023-10-20) -
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Oza, Amit M.; Lorusso, Domenica; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Elsevier, 2020-10-01) -
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
Moore, Kathleen N; Oaknin Benzaquen, Ana Mazaltob; Friedlander, Michael; Lisyanskaya, Alla; Scambia, Giovanni; Colombo, Nicoletta (Elsevier, 2021-10)